2019 Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Haematologica.
2019 Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Haematologica.
2019 State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019. Group Chronic Malignancies Working Party (CMWP) 1st listed author McLornan DP Journal Haematologica.
2019 Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Raj K Journal Biol Blood Marrow Transplant.
2019 Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP. Group Chronic Malignancies Working Party (CMWP) 1st listed author Hayden PJ Journal Eur J Haematol.
2019 Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gagelmann N Journal Biol Blood Marrow Transplant.
2019 Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Carré M Journal Biol Blood Marrow Transplant.
2019 A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cremers EMP Journal Leuk Lymphoma.
2019 Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia. Group Chronic Malignancies Working Party (CMWP) Lymphoma Working Party (LWP) Other society 1st listed author Michallet M Journal Bone Marrow Transplant.
2019 An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Hayden PJ Journal Curr Res Transl Med.
2019 Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gagelmann N Journal Haematologica.
2019 Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Br J Haematol.